Corresponding Author

College of Pharmacy, Xinxiang Medical University, Xinxiang, China

Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China

Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China

School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China

Correspondence Peng Li and Ya-ling Yin, College of Pharmacy, Xinxiang Medical University, Xinxiang 450003, China.

Email: 071021@xxmu.edu.cn (P. I.) and hnpdsyyl@163.com (Y.-L. Y.)